Related references
Note: Only part of the references are listed.Randomized Trial of Benznidazole for Chronic Chagas' Cardiomyopathy
C. A. Morillo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Revisiting the Posttherapeutic Cure Criterion in Chagas Disease: Time for New Methods, More Questions, Doubts, and Polemics or Time to Change Old Concepts?
Marta de Lana et al.
BIOMED RESEARCH INTERNATIONAL (2015)
Towards a Paradigm Shift in the Treatment of Chronic Chagas Disease
R. Viotti et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved
Jennifer K. Rogers et al.
EUROPEAN JOURNAL OF HEART FAILURE (2014)
Chagas Disease Cardiomyopathy: Immunopathology and Genetics
Edecio Cunha-Neto et al.
MEDIATORS OF INFLAMMATION (2014)
Chagas Disease: Still Many Unsolved Issues
Jose M. Alvarez et al.
MEDIATORS OF INFLAMMATION (2014)
Drug discovery for Chagas disease should consider Trypanosoma cruzi strain diversity
Bianca Zingales et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2014)
Chagas Disease and the London Declaration on Neglected Tropical Diseases
Rick L. Tarleton et al.
PLOS NEGLECTED TROPICAL DISEASES (2014)
Interferon-γ and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy
Ludmila Rodrigues Pinto Ferreira et al.
WORLD JOURNAL OF CARDIOLOGY (2014)
International differences in treatment effect: do they really exist and why?
Stuart Pocock et al.
EUROPEAN HEART JOURNAL (2013)
Polymorphism in the Alpha Cardiac Muscle Actin 1 Gene Is Associated to Susceptibility to Chronic Inflammatory Cardiomyopathy
Amanda Farage Frade et al.
PLOS ONE (2013)
Endothelial Transmigration by Trypanosoma cruzi
Bria M. Coates et al.
PLOS ONE (2013)
Pathogenesis of chronic Chagas cardiomyopathy: the role of coronary microvascular derangements
Jose Antonio Marin-Neto et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2013)
The revised Trypanosoma cruzi subspecific nomenclature: Rationale, epidemiological relevance and research applications
Bianca Zingales et al.
INFECTION GENETICS AND EVOLUTION (2012)
Deficient Regulatory T Cell Activity and Low Frequency of IL-17-Producing T Cells Correlate with the Extent of Cardiomyopathy in Human Chagas' Disease
Paulo Marcos Matta Guedes et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
Fexinidazole: A Potential New Drug Candidate for Chagas Disease
Maria Terezinha Bahia et al.
PLOS NEGLECTED TROPICAL DISEASES (2012)
I Diretriz Latino-Americana para o Diagnóstico e Tratamento da Cardiopatia Chagásica
Iran Castro et al.
Arquivos Brasileiros de Cardiologia (2011)
Pathogenesis of Chagas' Disease: Parasite Persistence and Autoimmunity
Antonio R. L. Teixeira et al.
CLINICAL MICROBIOLOGY REVIEWS (2011)
Trypanosoma cruzi in the Chicken Model: Chagas-Like Heart Disease in the Absence of Parasitism
Antonio R. L. Teixeira et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Use of benznidazole to treat chronic Chagas' disease: a systematic review with a meta-analysis
Jose A. Perez-Molina et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2009)
Chagas heart disease: pathophysiologic mechanisms, prognostic factors and risk stratification
Anis Rassi et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2009)
Rationale and design of a randomized placebo-controlled trial assessing the effects of etiologic treatment in Chagas' cardiomyopathy: The BENznidazole Evaluation For Interrupting Trypanosomiasis (BENEFIT)
Jose Antonio Marin-Neto et al.
AMERICAN HEART JOURNAL (2008)
Chagas heart disease pathogenesis: One mechanism or many?
Kevin M. Bonney et al.
CURRENT MOLECULAR MEDICINE (2008)
Current concepts in immunoregulation and pathology of human Chagas disease
Walderez O. Dutra et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2008)
Further evidence of spontaneous cure in human Chagas disease
Joao Carlos Pinto Dias et al.
REVISTA DA SOCIEDADE BRASILEIRA DE MEDICINA TROPICAL (2008)
The challenges of chagas disease -: Grim outlook or glimmer of hope?
Rick L. Tarleton et al.
PLOS MEDICINE (2007)
Evaluation and treatment of Chagas disease in the United States - A systematic review
Caryn Bern et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Pathogenesis of chronic Chagas heart disease
Jose Antonio Marin-Neto et al.
CIRCULATION (2007)
Mechanisms of pathogenesis in Chagas disease
Felipe Kierszenbaum
ACTA PARASITOLOGICA (2007)
Manifestations of Chagas disease (American trypanosomiasis) in patients with HIVAIDS
A. M. C. Sartori et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2007)
Development and validation of a risk score for predicting death in Chagas' heart disease
Anis Rassi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Induction of cardiac autoimmunity in Chagas heart disease: A case for molecular mimicry
E Cunha-Neto et al.
AUTOIMMUNITY (2006)
Treatment with benznidazole during the chronic phase of experimental Chagas' disease decreases cardiac alterations
S Garcia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Chagas disease: a role for autoimmunity?
RL Tarleton
TRENDS IN PARASITOLOGY (2003)
Trypanosoma cruzi reinfections in mice determine the severity of cardiac damage
JM Bustamante et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2002)
Parasite persistence in treated chagasic patients revealed by xenodiagnosis and polymerase chain reaction
C Britto et al.
MEMORIAS DO INSTITUTO OSWALDO CRUZ (2001)
Parasite polyclonal activators: new targets for vaccination approaches?
P Minoprio
INTERNATIONAL JOURNAL FOR PARASITOLOGY (2001)
Prevalence of circulating Trypanosoma cruzi detected by polymerase chain reaction in patients with Chagas' cardiomyopathy
OA Salomone et al.
AMERICAN JOURNAL OF CARDIOLOGY (2000)
Share Paper
